Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The clinical utility of genome-wide non invasive prenatal screening

17 Apr 2017

Abstract excerpt

OBJECTIVE: In this study, we expanded conventional cell-free fetal DNA (cfDNA)-based non-invasive prenatal testing (NIPT) to cover the entire genome. We aimed to compare the performance of the two tests in a large general population of pregnant women, in order to assess the clinical utility of the genome-wide screening. METHOD: Genome-wide cfDNA analysis was offered to 12 114 pregnant women undergoing NIPT for...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Genomics and Diagnostics
Share to Fetal and Pediatric Neurological Disorders
Share to Prenatal Screening and Diagnostics

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 28423190
DOI: 10.1002/pd.5053

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The clinical utility of genome-wide non invasive prenatal screeningPMID 28423190Read ↗

Noninvasive prenatal testing for chromosome aneuploidies and subchromosomal microdeletions/microduplications in a cohort of 42,910 single pregnancies with different clinical featuresSemantic proximity Read ↗

The evolution of cell-free fetal DNA testing: expanded non-invasive prenatal testing and its effect on target populationsSemantic proximity Read ↗

Clinical experience of genome-wide non-invasive prenatal testing as a first-tier screening test in a cohort of 59,771 pregnanciesSemantic proximity Read ↗

PREIMPLANTATION GENETIC TESTING: Non-invasive prenatal testing for aneuploidy, copy-number variants and single-gene disordersSemantic proximity Read ↗

Expanded non-invasive prenatal testing offers better detection of fetal copy number variations but not chromosomal aneuploidiesSemantic proximity Read ↗

Three years of clinical experience with a genome-wide cfDNA screening test for aneuploidies and copy-number variantsSemantic proximity Read ↗

Genomics-based non-invasive prenatal testing for detection of fetal chromosomal aneuploidy in pregnant womenSemantic proximity Read ↗

The application of expanded noninvasive prenatal screening for genome-wide chromosomal abnormalities and genetic counselingSemantic proximity Read ↗

Genome-wide cell-free DNA screening: a focus on copy-number variantsSemantic proximity Read ↗

Performance of expanded non-invasive prenatal testing for fetal aneuploidies and copy number variations: A prospective study from a single center in Jiangxi province, ChinaSemantic proximity Read ↗

Clinical application of expanded noninvasive prenatal testing for fetal chromosome abnormalities in a cohort of 39,580 pregnanciesSemantic proximity Read ↗

Clinical Validation of a Non-Invasive Prenatal Test for Genome-Wide Detection of Fetal Copy Number VariantsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.